Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26998
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGregory, Gillian-
dc.contributor.authorDas Gupta, Kuheli-
dc.contributor.authorMeiser, Bettina-
dc.contributor.authorBarlow-Stewart, Kristine-
dc.contributor.authorGeelan-Small, Peter-
dc.contributor.authorKaur, Rajneesh-
dc.contributor.authorScheepers-Joynt, Maatje-
dc.contributor.authorMcInerny, Simone-
dc.contributor.authorTaylor, Shelby-
dc.contributor.authorAntill, Yoland-
dc.contributor.authorSalmon, Lucinda-
dc.contributor.authorSmyth, Courtney-
dc.contributor.authorYoung, Mary-Anne-
dc.contributor.authorJames, Paul A-
dc.contributor.authorYanes, Tatiane-
dc.date2021-07-05-
dc.date.accessioned2021-07-12T06:10:17Z-
dc.date.available2021-07-12T06:10:17Z-
dc.date.issued2022-
dc.identifier.citationJournal of genetic counseling 2022; 31(1): 120-129en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26998-
dc.description.abstractHereditary breast cancer is associated with known genetic changes: either variants that affect function in a few rare genes or an ever-increasing number of common genomic risk variants, which combine to produce a cumulative effect, known as a polygenic risk (PR) score. While the clinical validity and utility of PR scores are still being determined, the communication of PR is a new challenge for genetic health professionals. This study investigated how PR scores are discussed in the familial cancer clinic compared with a previous study assessing the communication of monogenic risk (MR) for breast cancer. Sixty-five PR consultations between genetic health professionals and women at familial risk of breast cancer were audiotaped, transcribed, and coded using a methodology adapted from the MR study. Analysis of consultations shows that while there were similarities in communicating MR and PR, the complexity and novelty of the polygenic information influenced the style of counseling used by genetic health professionals toward a teaching model of genetic counseling, rather than a patient-centered approach. In particular, compared to MR consultations, in PR consultations significantly fewer counselees (a) were asked about their reasons for attending genetic counseling; or (b) had their information preferences, decision-making style, medical knowledge, understanding, or concerns checked. In conclusion, it is anticipated that PR scores will become part of standard clinical practice. Thus, it will be important for all genetic health professionals to be appropriately educated so that they can tailor their communication to meet patient needs.en
dc.language.isoeng-
dc.subjectcommunicationen
dc.subjectfamily historyen
dc.subjectgenetic counselingen
dc.subjectgenetic testingen
dc.subjectpolygenic risk scoresen
dc.titlePolygenic risk in familial breast cancer: Changing the dynamics of communicating genetic risk.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Genetic Counselingen
dc.identifier.affiliationDermatology Research Centre, Diamantina Institute, University of Queensland, Brisbane, QLD, Australiaen
dc.identifier.affiliationKinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australiaen
dc.identifier.affiliationSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australiaen
dc.identifier.affiliationPsychosocial Research Group, Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australiaen
dc.identifier.affiliationFaculty of Medicine and Health, Northern Clinical School, University of Sydney, Sydney, NSW, Australiaen
dc.identifier.affiliationParkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne VIC, Australiaen
dc.identifier.affiliationFamilial Cancer Clinic, Cabrini Health, Melbourne, VIC, Australiaen
dc.identifier.affiliationFaculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australiaen
dc.identifier.affiliationClinical Geneticsen
dc.identifier.affiliationFamilial Cancer Clinic, Monash Medical Centre, Melbourne, VIC, Australiaen
dc.identifier.doi10.1002/jgc4.1458en
dc.type.contentTexten
dc.identifier.pubmedid34223688-
local.name.researcherSalmon, Lucinda
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptClinical Genetics-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Nov 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.